Abstract LB-305: Circulating tumor cells as a novel model to test efficacy of individualized therapy in breast cancer
Mario Giuliano(Regione Campania), Rachel Schiff(Baylor College of Medicine), Sabrina Herrera(Mayo Clinic), Alejandro Contreras(Baylor College of Medicine), Michael T. Lewis(Baylor College of Medicine), Sufeng Mao(Baylor College of Medicine), Meghana V. Trivedi(University of Houston), Mothaffar F. Rimawi(Baylor College of Medicine), Osborne K. Charles(Baylor College of Medicine), Pavel Christiny(University of Houston), Xiaomei Zhang(The University of Sydney), Gary C. Chamness(Baylor College of Medicine)
Cited by 0
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
|Endocrine Reviews|2008|545